Cybin announces date of annual and special meeting of shareholders

Toronto--(business wire)--cybin inc. (nyse american:cybn) (neo:cybn) (“cybin” or the “company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today announced that its 2023 annual and special meeting of shareholders will be held virtually on thursday, october 12, 2023 at 1:00 p.m. et. the notice of annual and special meeting and proxy statement containing meeting details are availab.
CYBN Ratings Summary
CYBN Quant Ranking